Stockreport

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial [Yahoo! Finance]

Nexalin Technology, Inc.  (NXL) 
PDF Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that it has successfully enrolled the first patients in its clinical trial at the University of [Read more]